Evaluating the Efficacy and Stability of Expired Ciprofloxacin: A Comprehensive Assessment
الكلمات المفتاحية:
سيبروفلوكساسين، المضادات الحيوية، فعالية الدواء، استقرار الدواء، جودة المستحضرات الصيدلانيةالملخص
الأدوية التي تجاوزت تاريخ صلاحيتها قد تتعرض للتحلل، مما يؤدي إلى فقدان فعاليتها أو احتمال تحولها إلى مواد ضارة. توصي شركات تصنيع الأدوية وبعض الجهات الصحية عادةً بالتخلص من الأدوية عند انتهاء تاريخ الصلاحية المدون على العبوة. ومع ذلك، من المهم الإشارة إلى أن تاريخ الصلاحية لا يعني بالضرورة أن الدواء قد أصبح غير صالح للاستخدام بشكل قاطع. وتعتبر صلاحية المضادات الحيوية ذات أهمية خاصة، إذ يضمن المستهلك حتى هذا التاريخ أن الدواء فعال ومستقر وآمن. بعد هذا التاريخ، قد يتحلل المكون الفعّال، مما يؤدي إلى انخفاض الفعالية وفشل علاج العدوى، وهو ما قد يسهم في ظهور مقاومة للمضادات الحيوية. تهدف هذه الدراسة إلى مقارنة النشاط المضاد للميكروبات لدواء سيبروفلوكساسين Ciprofloxacin منتهي الصلاحية كمثال على المضادات الحيوية ضد سلالات بكتيرية معيارية، مع النشاط المضاد للسيبروفلوكساسين Ciprofloxacin غير منتهي الصلاحية. يمكن أن تسهم نتائج هذه الدراسة في وضع إرشادات حول الاستخدام الآمن للمضادات الحيوية منتهية الصلاحية. استخدمت الدراسة عدة سلالات بكتيرية (Staphylococcus aureus, Escherichia coli, Salmonella and Shigella Flexenari)، وأظهر التناسق في النتائج عبر جميع السلالات أن السيبروفلوكساسين منتهي الصلاحية قد يظل فعالاً. ومع ذلك، لم تقيّم الدراسة ديناميكية تحلل السيبروفلوكساسين على المدى الطويل، بل قارنت فقط بين نقطتين زمنيتين (منتهي الصلاحية وغير منتهي الصلاحية). كما أن زيادة حجم العينة واستخدام دفعات متعددة من السيبروفلوكساسين منتهي الصلاحية من شأنه أن يعزز موثوقية النتائج. هناك حاجة إلى مزيد من الأبحاث المخبرية لتقييم فعالية المضادات الحيوية منتهية الصلاحية، خاصةً في البلدان التي تعاني من نقص الأدوية أو خلال حالات الطوارئ. وينبغي على المرضى تجنب استخدام المضادات الحيوية منتهية الصلاحية دون استشارة مختصين، حتى وإن بدت فعّالة، وذلك لتقليل مخاطر انخفاض الفعالية أو تطور مقاومة بكتيرية. بالإضافة إلى ذلك، يُوصى بتوفير إرشادات تنظيمية واضحة من الجهات الصحية المختصة (مثل وزارات الصحة أو هيئات الغذاء والدواء) بشأن الاستخدام الآمن لبعض الأدوية منتهية الصلاحية عند الضرورة.
التنزيلات
المراجع
American Medical Association, Council on Scientific Affairs. (2001). Pharmaceutical expiration dates (Report No. 1 of the Council on Scientific Affairs, A-01). https://www.ama-assn.org
Anderson, G., & Scott, M. (1991). Determination of product shelf life and activation energy for five drugs of abuse. Clinical Chemistry, 37, 398–402.
Bajaj, S., Singla, D., & Sakhuja, N. (2012). Stability testing of pharmaceutical products. Journal of Applied Pharmaceutical Science, 2(3), 129–138.
Blondeau, J. M. (1999). Expanded activity and utility of the new fluoroquinolones: A review. Clinical Therapeutics, 21(1), 3–15. https://doi.org/10.1016/S0149-2918(00)88274-9
Campoli-Richards, D. M., Monk, J. P., Price, A., Benfield, P., Todd, P. A., & Ward, A. (1988). Ciprofloxacin: A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs, 35(4), 373–447. https://doi.org/10.2165/00003495-198835040-00002
Cantrell, L., Suchard, J., Wu, A., & Gerona, R. (2012). Stability of active ingredients in long-expired prescription medications. Archives of Internal Medicine, 172(21), 1685–1687. https://doi.org/10.1001/archinternmed.2012.4382
Carstensen, J. T. (2000). Drug stability: Principles and practices (3rd ed.). Marcel Dekker.
Coker, T. J., & Dierfeldt, D. M. (2016). Acute bacterial prostatitis: Diagnosis and management. American Family Physician, 93(2), 114–120.
Cozzani, E., Chinazzo, C., Burlando, M., Romagnoli, M., & Parodi, A. (2016). Ciprofloxacin as a trigger for bullous pemphigoid: The second case in the literature. American Journal of Therapeutics, 23(5), e1202–e1204. https://doi.org/10.1097/MJT.0000000000000262
Davido, B., Michelon, H., Mamona, C., de Truchis, P., Jaffal, K., & Saleh-Mghir, A. (2024). Efficacy of expired antibiotics: A real debate in the context of repeated drug shortages. Antibiotics, 13(5), Article 466. https://doi.org/10.3390/antibiotics13050466
Dawson, M. (1994). Expiry dates. Australian Prescriber, 17(2), 46–48. https://doi.org/10.18773/austprescr.1994.051
Downey, P. J. (2015). Kinetics and salting-in of aspirin in aqueous acetic acid solutions: Shelf-life estimation. Journal of Pharmaceutical Sciences, 104(5), 1600–1607. https://doi.org/10.1002/jps.24374
Emmerson, A. M., & Jones, A. M. (2003). The quinolones: Decades of development and use. Journal of Antimicrobial Chemotherapy, 51(Suppl. 1), 1–10. https://doi.org/10.1093/jac/dkg208
Getahun, H., Belew, S., Hasen, G., Tefera, G., Mekasha, Y. T., & Suleman, S. (2024). Quality evaluation of selected expired fluoroquinolones medicines obtained from the public hospitals in Jimma zone, Oromia regional state, Ethiopia. Frontiers in Medicine, 11, Article 1420146. https://doi.org/10.3389/fmed.2024.1420146
Heras-Cañas, V., Gutiérrez-Soto, B., Almonte-Fernández, H., Lara-Oya, A., Navarro-Marí, J. M., Garrido-Frenich, A., Vázquez-Alonso, F., & Gutiérrez-Fernández, J. (2017). Antibiotic activity and concentrations in clinical samples from patients with chronic bacterial prostatitis. Actas Urológicas Españolas, 41(10), 635–641. https://doi.org/10.1016/j.acuro.2017.03.008
Khanchandani, R., Srivastava, B., Sinha, A., Gaur, S., Gaur, S., & Bharat, S. (2015). Efficacy, safety concern and disposal practices followed for expired drug preparations among medical personnel. International Journal of Current Research, 7(8), 19456–19461.
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010). How antibiotics kill bacteria: From targets to networks. Nature Reviews Microbiology, 8(6), 423–435. https://doi.org/10.1038/nrmicro2333
Kommanaboyina, B., & Rhodes, C. T. (1999). Trends in stability testing, with emphasis on stability during distribution and storage. Drug Development and Industrial Pharmacy, 25(7), 857–868. https://doi.org/10.1081/DDC-100102196
LeBel, M. (1988). Ciprofloxacin: Chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions. Pharmacotherapy, 8(1), 3–30. https://doi.org/10.1002/j.1875-9114.1988.tb03565.x
Lyon, R., Taylor, J., Porter, D., Prasanna, H., & Hussain, A. (2006). Stability profiles of drug products extended beyond labeled expiration dates. Journal of Pharmaceutical Sciences, 95(7), 1549–1560. https://doi.org/10.1002/jps.20636
McDonnell, N. J., & Jacob, E. (2015). Adverse effects of antibiotics and safety considerations in their use. Australian Prescriber, 38(3), 88–91. https://doi.org/10.18773/austprescr.2015.038
Mohamed, S., Elmohamady, M. N., Abdelrahman, S., Amer, M. M., & Abdelhamid, A. G. (2020). Antibacterial effects of antibiotics and cell-free preparations of probiotics against Staphylococcus aureus and Staphylococcus epidermidis associated with conjunctivitis. Saudi Pharmaceutical Journal, 28(12), 1755–1762. https://doi.org/10.1016/j.jsps.2020.10.012
Meyerhoff, A., Albrecht, R., Meyer, J. M., Dionne, P., Higgins, K., & Murphy, D. (2004). US Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax. Clinical Infectious Diseases, 39(3), 303–308. https://doi.org/10.1086/421999
Owens, R. C., Jr., & Ambrose, P. G. (2005). Antimicrobial safety: Focus on fluoroquinolones. Clinical Infectious Diseases, 41(Suppl. 2), S144–S157. https://doi.org/10.1086/428051
Przyswa, E. (2013). Counterfeit medicines and criminal organisations. IRCAM.
Ramachandran, S. (2016). Drugs past their expiration date. Journal of the American Medical Association, 315(5), 510–511. https://doi.org/10.1001/jama.2015.19678
Regenthal, R., Stefanovic, D., Albert, T., Trauer, H., & Wolf, T. (2002). The pharmacologic stability of 35-year old theophylline. Human & Experimental Toxicology, 21(7), 343–346. https://doi.org/10.1191/0960327102ht267oa
Rehman, A., Patrick, W. M., & Lamont, I. L. (2019). Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: New approaches to an old problem. Journal of Medical Microbiology, 68(1), 1–10. https://doi.org/10.1099/jmm.0.000876
Richter, B., Bongaerts, B., & Metzendorf, M.-I. (2023). Thermal stability and storage of human insulin. Cochrane Database of Systematic Reviews, 2023(11), Article CD015385. https://doi.org/10.1002/14651858.CD015385
Rudolph, A., Dahmke, H., Kupferschmidt, H., Burden, A., & Weiler, S. (n.d.). Coadministration of tizanidine and ciprofloxacin: A retrospective analysis of the WHO pharmacovigilance database. European Journal of Clinical Pharmacology.
Šljivić Husejnović, M., Suljić, A., Taletović, A., Džambić, A., Ibišević, M., Smajlagić, A., Kozarević, E. C., Karić, E., & Haličević, A. (2025). [Title and journal information needed].
Smith, J. (2020). Pharmaceutical stability and efficacy. Journal of Pharmaceutical Sciences, 109(3), 123–130. https://doi.org/10.1016/j.xphs.2019.11.015
Tura, A., Dalecha, D., Yasir, M., Ketebo, T., & Noorulla, K. (2022). Expiry of medicine in public health facilities of Arsi Zone, Oromia Regional State, Ethiopia: A quantitative and qualitative study. Current Issues in Pharmacy and Medical Sciences, 35, 27–33. https://doi.org/10.2478/cipms-2022-0004
Unemo, M., Lahra, M. M., Cole, M., Galarza, P., Ndowa, F., Martin, I., Dillon, J. R., Ramon-Pardo, P., Bolan, G., & Wi, T. (2019). World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): Review of new data and evidence to inform international collaborative actions and research efforts. Sexual Health, 16(6), 517–529. https://doi.org/10.1071/SH19023
Ventola, C. L. (2015). The antibiotic resistance crisis: Part 1: Causes and threats. Pharmacy and Therapeutics, 40(4), 277–283.
Waksman, S. A. (1947). What is an antibiotic or an antibiotic substance? Mycologia, 39(5), 457–465. https://doi.org/10.1080/00275514.1947.12020685
Zhang, H. L., Tan, M., Qiu, A. M., Tao, Z., & Wang, C. H. (2017). Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: A network analysis. BMC Pulmonary Medicine, 17, Article 175. https://doi.org/10.1186/s12890-017-0517-0
Shlibak, A. A. A., & Dalla, L. O. F. B. (2020). The sustainable research long while between bee pollen and honey bee diversity in Libya: Literature review. International Journal of Social Sciences and Management Research, 7(1), 2545–5303.
Abdulla, S. A., Elshaari, F. A., Alshintari, M., & Zourgui, L. (2025). Phytochemical profiling and biological activity of the ethanolic extract of Phragmites australis. Open Veterinary Journal, 15(6), 2478. https://doi.org/10.5455/OVJ.2025.v15.i6.1
Benramadan, L., Abozid, A., & Alshintari, M. (2026). Comparative analysis of phenolic compounds in coffee prepared by American and Arabic brewing methods. Wadi Alshatti University Journal of Pure and Applied Sciences, 218–222.
Alapid, A., Alshintari, M., Alforjani, A., Albosefi, R., & Yahmid, M. (2025). Antioxidant activity of natural chamomile and commercial chamomile in Libya: A comparative study. Libyan Medical Journal, 205–209.
Alshintari, M. E., Bonner, P. L., & Hargreaves, A. J. (2023). Effect of dietary flavonoids on amine incorporation activity of transglutaminase 2 enzyme. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences, 3(1), 64–69. https://doi.org/10.5281/zenodo.7890123
Alshintari, M., Dhaw, E., & Alagnaf, M. (2025). Papillary thyroid cancer: Prevalence, diagnosis methods, symptoms and management options in Tripoli, Libya. AlQalam Journal of Medical and Applied Sciences, 340–344.
Alshintari, M., Salem, M. A., Mohamed, H., Elgheriani, M. R., Omran, H., Al-Jnaf, D., & Zidan, M. (2025). A comparative study of maceration and Soxhlet extraction for antibacterial activity of rosemary (Rosmarinus officinalis) leaves. [Journal information needed].
Abozid, A., Benramadan, L., & Alshintari, M. (2025). The influence of preparation methods on phenolic compounds content in green tea samples from the Libyan market. AlQalam Journal of Medical and Applied Sciences, 1072–1075.
Shlibak, A. A., Örgeç, M., & Zencirci, N. (2021). Wheat landraces versus resistance to biotic and abiotic stresses. In Wheat landraces (pp. 193–214). Springer International Publishing. https://doi.org/10.1007/978-3-030-67896-5_10
Shlıbak, A., & Zencirci, N. (2021). Wheat: Biotrophic fungi and resistance genes. Uluslararası Anadolu Ziraat Mühendisliği Bilimleri Dergisi, 3(1), 10–20.
Soliman, A., Mohamed, N., Almiar, F., & Shlibak, A. (2026). Effect of fenugreek (Trigonella foenum-graecum L.) extract on early growth parameters of Phaseolus vulgaris L. AlQalam Journal of Medical and Applied Sciences, 416–420.
Ben Dalla, L. O. F., Medeni, T. D., Medeni, I. T., & Ulubay, M. (2025). Enhancing healthcare efficiency at Almasara Hospital: Distributed data analysis and patient risk management. Economy: Strategy and Practice, 19(4), 54–72. https://doi.org/10.51176/1997-9967-2024-4-54-72
Dalla, L. O. F. B. (2020). Modeling by using Generic Modeling Environment (GME) domain-specific modeling language (DSL) for agile software development (ASD) types. [Publication information needed].
Alsharif, A., Ahmed, A. A., Musa, Z. A., Dalla, L. O. F. B., & Nouh, A. (2026). Drugs: The path of darkness between religious awareness and societal loss. International Journal of Academic Publishing in Educational Sciences and Humanities, 2(1), 49–56.
Alsharif, A., Solman, F. I., Gheidan, A. A. S., Ahmed, A. A., Dalla, L. O. F. B., Alsharif, M. A., & Imbayah, I. (2026). Photovoltaic cells: Principles of operation and performance characteristics. Journal of Scientific and Human Dimensions, 718–748. https://doi.org/10.65421/jshd.v2i1.122
Dalla, L. O. F. B. (2020). The influence of hospital management framework by the usage of electronic healthcare record to avoid risk management (Department of Communicable Diseases at Misurata Teaching Hospital: Case study). Electronic Healthcare Record Management, 20(4), 22–52. https://doi.org/10.51176/1954-9923-2020-4-22-52
